Insider Transactions in Q4 2025 at Cadrenal Therapeutics, Inc. (CVKD)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,315
-0.67%
|
$17,095
$13.99 P/Share
|
|
Oct 27
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-15.34%
|
$23,400
$13.99 P/Share
|
|
Oct 24
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,129
-0.57%
|
$15,806
$14.03 P/Share
|
|
Oct 24
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-13.3%
|
$23,400
$13.99 P/Share
|
|
Oct 13
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,800
-0.9%
|
$25,200
$14.15 P/Share
|
|
Oct 13
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-11.74%
|
$25,200
$14.07 P/Share
|
|
Oct 09
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,800
-0.89%
|
$25,200
$14.02 P/Share
|
|
Oct 09
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,693
-9.94%
|
$22,009
$13.99 P/Share
|
|
Oct 06
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.62%
|
$1,391
$13.99 P/Share
|
|
Oct 02
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
500
-0.25%
|
$7,000
$14.13 P/Share
|
|
Oct 01
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
881
-0.43%
|
$12,334
$14.01 P/Share
|
|
Oct 01
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,700
-9.03%
|
$22,100
$13.99 P/Share
|